|
|
|
|
| Symbol | Name | Pre-Tax Profit Margin | Leverage Ratio | Current Ratio | Price / Book Ratio | Price / Cash Flow Ratio | Price / Free Cash Flow Ratio | Debt / Equity Ratio | Price / Sales Ratio | Income per Employee | Last | Volume |
| |
Acumen Pharmaceuticals Inc | |
1.16 |
19.01 |
0.68 |
|
-3.45 |
0.11 |
539 |
-1,007,135 |
3.18 |
152,247 |
| |
Abits Group Inc | |
1.03 |
9.29 |
1.37 |
1.03 |
1.00 |
0.00 |
263 |
-2,008,417 |
0.7595 |
3,102 |
| |
Abivax S.A. ADR | |
1.67 |
4.08 |
4.71 |
|
-4.65 |
0.28 |
137 |
-6,190,846 |
15.89 |
7,484 |
| |
Acasti Pharma Inc | |
1.18 |
15.19 |
0.42 |
|
-2.09 |
0.00 |
208 |
-1,211,688 |
2.90 |
8,025 |
| |
AIM ImmunoTech Inc | |
1.89 |
1.68 |
2.40 |
|
-1.06 |
0.07 |
116 |
-1,206,750 |
0.43 |
157,939 |
| |
Allogene Therapeutics Inc | |
1.25 |
12.38 |
1.14 |
|
-2.25 |
0.19 |
6,764 |
|
3.04 |
2,086,260 |
| |
Altimmune Inc | |
1.09 |
17.26 |
2.52 |
|
-4.82 |
0.00 |
864 |
-1,499,102 |
7.08 |
2,173,625 |
| |
ALX Oncology Holdings Inc | |
1.28 |
5.24 |
4.11 |
|
-5.11 |
0.09 |
5,906 |
-2,264,859 |
16.22 |
440,803 |
| |
Anixa Biosciences Inc | |
1.03 |
15.19 |
3.96 |
|
-14.69 |
0.01 |
439 |
-1,790,667 |
3.18 |
355,911 |
| |
Aqua Metals Inc | |
1.29 |
3.97 |
2.02 |
|
-3.89 |
0.12 |
2,484 |
-451,660 |
0.4821 |
364,785 |
|
Please sign up to view the complete list of stocks. |
|
|
|
| |
